Content about HIV

April 2, 2013

DSN caught up with Greg Bradley — president and CEO of Advantage Consumer Healthcare, a full turnkey solution center for over-the-counter medicines reaching the market — for an overview of the new marketing and sales solution company as it has recently brought to market OraSure Technologies' OraQuick Advance, a take-home HIV test kit that the Food and Drug Administration recently approved for the self-care market, and Westport Pharmaceuticals' Zephrex-D, a pseudoephedrine product with a unique point of differentiation.

AUDIO Q&A: DSN caught up with Greg Bradley — president and CEO of Advantage Consumer Healthcare, a full turnkey solution center for over-the-counter medicines reaching the market — for an overview of the new marketing and sales solution company as it has recently brought to market OraSure Technologies' OraQuick Advance, a take-home HIV test kit that the Food and Drug Administration recently approved for the self

December 27, 2012

The Obama administration recently stressed the importance of increasing coverage of HIV treatment, as well as increasing access to HIV testing and counseling. It's an initiative that Walgreens, with more than 700 HIV-specialized pharmacies and over 2,000 pharmacists with special HIV/AIDS-accredited educational training, follows closely. Walgreens' senior manager for HIV/AIDS and hepatitis pharmacy services Glen Pietrandoni talked with DSN on the scope of Walgreens' HIV/AIDS services.

AUDIO Q&A: Walgreens' senior manager for HIV/AIDS and hepatitis pharmacy services Glen Pietrandoni talked with DSN on the scope of Walgreens' HIV/AIDS services.The Obama administration recently stressed the importance of increasing coverage of HIV treatment, as well as increasing access to HIV testing and counseling.

April 18, 2014

Evidence-based interventions at the local and national levels provide promising strategies for reducing racial and ethnic health disparities related to HIV infection rates, immunization coverage, motor vehicle injuries and deaths, and smoking, according to a new report by the CDC's Office of Minority Health and Health Equity released Thursday.

ATLANTA — Evidence-based interventions at the local and national levels provide promising strategies for reducing racial and ethnic health disparities related to HIV infection rates, immunization coverage, motor vehicle injuries and deaths, and smoking, according to a new report by the CDC's Office of Minority Health and Health Equity released Thursday.

April 15, 2014

Total spending on U.S. medicines increased 1% on a real per capita basis in 2013, while the use of healthcare services overall rose for the first time in three years, according to a new report issued today by the IMS Institute for Healthcare Informatics.

PARSIPPANY, N.J. — Total spending on U.S. medicines increased 1% on a real per capita basis in 2013, while the use of healthcare services overall rose for the first time in three years, according to a new report issued today by the IMS Institute for Healthcare Informatics.

February 11, 2014

In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists’ training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise, the retailer announced Tuesday.

DEERFIELD, Ill. — In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists’ training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise, the retailer announced Tuesday.

February 7, 2014

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

A new and possibly transformative technology for rapidly diagnosing and evaluating patients based on their specific genetic profile may soon begin appearing at retail pharmacies and clinics, giving pharmacists and clinicians another tool for advancing patient health outcomes and their own practice capabilities.

Dr. Anita Goel, M.D., Ph.D.

January 10, 2014

The Food and Drug Administraiton has approved a liquid formulation of an HIV drug made by Merck, the company said.

WHITEHOUSE STATION, N.J. — The Food and Drug Administraiton has approved a liquid formulation of an HIV drug made by Merck, the company said.

Merck announced the approval of Isentress (raltegravir) for oral suspension, aimed at small children with HIV. The drug may be used by patients as young as four weeks, and the full line of formulations of Isentress now includes the orlal suspension, as well as chewable tablets and film--coated tablets. The company plans to launch the oral suspension in the third quarter of this year.

December 27, 2013

The Food and Drug Administration has approved an HIV pill made by Gilead Sciences for patients who are switching from other therapy regimens, the company said.

FOSTER CITY, Calif. — The Food and Drug Administration has approved an HIV pill made by Gilead Sciences for patients who are switching from other therapy regimens, the company said.

Gilead said the FDA approved its single-pill regimen, Complera (emtricitabine; rilpivirine; tenofovir disoproxil fumarate) for use in adult patients who have suppressed their infections on stable antiretroviral regimens and are replacing their current regimens. The FDA originally approved the drug in 2011.

December 18, 2013

Lupin has launched a generic drug for treating HIV, following its victory in a patent-infringement suit in federal court, the Indian drug maker said Wednesday.

BALTIMORE — Lupin has launched a generic drug for treating HIV, following its victory in a patent-infringement suit in federal court, the Indian drug maker said Wednesday.

Lupin's U.S. subsidiary launched its generic version of ViiV Healthcare's Trizivir (abacavir sulfate; lamivudine; zidovudine) tablets in the 300-mg/150-mg/300-mg strength. The launch follows a ruling by the U.S. District Court for the District of Delaware that the drug did not infringe on Viiv's patent.

December 16, 2013

In support of the more than 1.1 million people living with HIV in the United States, Walgreens on Monday announced its collaboration with the Centers for Disease Control and Prevention to develop and evaluate a model of HIV patient-centered care through a national project aimed at advancing clinical integration and medication therapy management.

DEERFIELD, Ill. — In support of the more than 1.1 million people living with HIV in the United States, Walgreens on Monday announced its collaboration with the Centers for Disease Control and Prevention to develop and evaluate a model of HIV patient-centered care through a national project aimed at advancing clinical integration and medication therapy management. The program is another way Walgreens is extending its commitment to improve HIV prevention and treatment outcomes.

December 9, 2013

Two patients in Boston whom researchers had thought were cured of HIV have experienced a relapse of the infection, according to published reports.

NEW YORK — Two patients in Boston whom researchers had thought were cured of HIV have experienced a relapse of the infection, according to published reports.

The New York Daily News reported that the two men, who were believed cured after receiving bone marrow transplants for lymphoma, had the virus return.

December 4, 2013

The availability of new generic drugs for treating HIV will erode sales of HIV antiretroviral drugs into the next decade in developed countries, according to a new report.

BURLINGTON, Mass. — The availability of new generic drugs for treating HIV will erode sales of HIV antiretroviral drugs into the next decade in developed countries, according to a new report.

Healthcare market research firm Decision Resources released the report Wednesday, showing that sales of antiretroviral drugs in the United States, France, Germany, the United Kingdom, Spain, Italy and Japan would be $13.1 billion in 2022, down from 2012's $13.4 billion.

December 2, 2013

Drug maker Mylan and the Elton John AIDS Foundation will donate $1 million to the Business Leadership Council for a Generation Born HIV Free, the two said.

PITTSBURGH — Drug maker Mylan and the Elton John AIDS Foundation will donate $1 million to the Business Leadership Council for a Generation Born HIV Free, the two said.

November 26, 2013

Drug maker AbbVie is launching an international awareness campaign focused on women living with HIV, the drug maker said Tuesday.

NORTH CHICAGO, Ill. – Drug maker AbbVie is launching an international awareness campaign focused on women living with HIV, the drug maker said Tuesday.

November 20, 2013

Trigg Laboratories, makers of Wet personal lubricants, will be supporting World AIDS Day on Dec. 1 through the donation of more than 5,000 safe-sex kits and samples to local clinics across nine cities to help raise awareness around HIV/AIDS, the company announced Tuesday.

LOS ANGELES — Trigg Laboratories, makers of Wet personal lubricants, will be supporting World AIDS Day on Dec. 1 through the donation of more than 5,000 safe-sex kits and samples to local clinics across nine cities to help raise awareness around HIV/AIDS, the company announced Tuesday.

November 14, 2013

Antiretroviral drugs have allowed people with HIV to live normal life spans, but because of this, they also are susceptible to many new health complications, according to care guidelines released Thursday by the Infectious Diseases Society of America.

ARLINGTON, Va. — Antiretroviral drugs have allowed people with HIV to live normal life spans, but because of this, they also are susceptible to many new health complications, according to care guidelines released Thursday by the Infectious Diseases Society of America.

November 12, 2013

Walgreens recently presented research from two retrospective cohort studies exploring HIV and comorbid medication adherence at HIV-specialized pharmacies and the implications for HIV patients with serious mental illness.

DEERFIELD, Ill. — Walgreens recently presented research from two retrospective cohort studies exploring HIV and comorbid medication adherence at HIV-specialized pharmacies and the implications for HIV patients with serious mental illness. The research, presented at the Cell-Lancet conference, "What Will it Take to Achieve an AIDS-free World?," in San Francisco Nov.

November 8, 2013

With more than $7.2 million in sales for the 52 weeks ended Sept. 8, the landmark launch of Orasure Technologies’ OraQuick In-Home HIV test last year was a key driver behind the 11.7% growth in the home-test kit across U.S. multi-outlets, according to IRI.

BETHLEHEM, Pa. — With more than $7.2 million in sales for the 52 weeks ended Sept. 8, the landmark launch of Orasure Technologies’ OraQuick In-Home HIV test last year was a key driver behind the 11.7% growth in the home-test kit across U.S. multi-outlets, according to IRI. The OraQuick In-Home HIV Test detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes.

October 10, 2013

While the boom in generic drugs now looks set to wane, another segment of the pharmaceutical industry is rapidly rising and presenting new growth opportunities for pharmacy retailers: specialty drugs.

While the boom in generic drugs now looks set to wane, another segment of the pharmaceutical industry is rapidly rising and presenting new growth opportunities for pharmacy retailers: specialty drugs.

September 4, 2013

A joint venture founded by GlaxoSmithKline and Pfizer focused on treatments for HIV has expanded its support of community organizations in the South.

RESEARCH TRIANGLE PARK, N.C. — A joint venture founded by GlaxoSmithKline and Pfizer focused on treatments for HIV has expanded its support of community organizations in the South.

August 23, 2013

HIV continues to disproportionately affect African-Americans and Hispanics, prompting a recent seminar in New York that included pop singer Alicia Keys, New York Democratic Rep. Charlie Rangel and others.

NEW YORK — While a multitude of drugs have come on the market for treating HIV, the disease continues to disproportionately affect African-Americans and Hispanics, prompting a recent seminar in New York that included pop singer Alicia Keys, New York Democratic Rep. Charlie Rangel and others.

August 20, 2013

Chris Geronsin, owner of Beverly Hills Pharmacy in St. Louis, was honored with Cardinal Health’s Ken Wurster Community Leadership Award during the closing ceremonies at the Cardinal Health annual Retail Business Conference in Seattle on Friday, Aug. 9, at the Washington State Convention Center.

SEATTLE — Chris Geronsin, owner of Beverly Hills Pharmacy in St. Louis, was honored with Cardinal Health’s Ken Wurster Community Leadership Award during the closing ceremonies at the Cardinal Health annual Retail Business Conference in Seattle on Friday, Aug. 9, at the Washington State Convention Center.

August 13, 2013

The Food and Drug Administration approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection that is manufactured by GlaxoSmithKline.

WASHINGTON — The U.S. Food and Drug Administration on Monday approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection that is manufactured by GlaxoSmithKline.

Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to multiply. It is a pill taken daily in combination with other antiretroviral drugs.

August 7, 2013

Community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV and quickly connecting those who test positive with medical care, according to researchers at Albert Einstein College of Medicine of Yeshiva University.

BRONX, N.Y. — Community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV and quickly connecting those who test positive with medical care, according to researchers at Albert Einstein College of Medicine of Yeshiva University.

The study is in the August issue of the journal AIDS Patient Care and STDs.

July 16, 2013

Pharmacists in Indiana want an active consultation role when customers purchase over-the-counter HIV tests, according to a new study.

BLOOMINGTON, Ind. — Pharmacists in Indiana want an active consultation role when customers purchase over-the-counter HIV tests, according to a new study.

Researchers at Indiana University, Butler University and the Rural Center for AIDS/STD Prevention, lead by center co-director Beth Meyerson, said that community pharmacists have a unique opportunity to consult with customers about HIV treatment when selling OTC HIV tests. Engaged and supportive pharmacists, the researchers said, could help increase the number of those who test for HIV and who are linked to treatment.